The anticancer drugs have evolved significantly, spanning molecular targeted therapeutics (MTTs), immune checkpoint inhibitors (ICIs), chimeric antigen receptor T-cell (CAR-T) therapy, and antibody-drug conjugates (ADCs). Complications associated with these drugs vary widely based on their mechanisms of action. MTTs that target angiogenesis can often lead to complications related to ischemia or endothelial damage across various organs, whereas non-anti-angiogenic MTTs present unique complications derived from their specific pharmacological actions. ICIs are predominantly associated with immunerelated adverse events, such as pneumonitis, colitis, hepatitis, thyroid disorders, hypophysitis, and sarcoid-like reactions. CAR-T therapy causes unique and severe complications including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. ADCs tend to cause complications associated with cytotoxic payloads. A comprehensive understanding of these drug-specific toxicities, particularly using medical imaging, is essential for providing optimal patient care. Based on this knowledge, radiologists can play a pivotal role in multidisciplinary teams. Therefore, radiologists must stay up-to-date on the imaging characteristics of these complications and the mechanisms underlying novel anticancer drugs.

For patients with edentulous maxillae, creating a prosthetic treatment plan involves considering anatomical factors, aesthetics, the patient’s financial situation, and oral hygiene capabilities. In this case, CAD-CAM technology was used to accurately plan implant placements for a full arch fixed restoration based on the design of the final prosthesis. A customized surgical guide ensured precise implant placement and a provisional restoration was created using CAD-CAM. The definitive prosthesis was then created based on the second provisional restoration that has been previously used and adjusted by the patient. This approach achieved an excellent functional and aesthetic outcome, highlighting the benefits of digital approach and its potential for further clinical applications.

Purpose: . The purpose of this study is to analyze the biomechanical differences in rotation angle-torque according to the type of implant and to compare the effects of contamination and sandblasting on the removal torque value (RTV) of abutment screws. Materials and methods: . For this study, an automated device for tightening and loosening implant screws was developed, and each 15 implant-abutment complexes of external and internal connection type were prepared, divided into three groups according to the surface treatment of the screw:control group (no treatment), experimental group-1 (artificial saliva contamination and chlorhexidine (CHX) rinsing), and experimental group-2 (artificial saliva contamination, CHX rinsing, and subsequent 50 µm Al 2 O 3 sandblasting). FirstRTV was measured for each group, followed by different post-treatment procedures for the screws, and then Second-RTV was measured. During the procedure, the removal torque value and rotation angle vs. time were recorded at a 20 data/s.A standardized protocol was followed for all the tightening and loosening procedures: screw was tightened with 30 Ncm torque and maintained for 5 s, and then rotated in the reverse direction until the torque value reached 0 Ncm. After 10min of rest period, the screws were loosened to initial point. Results: . Statistical analysis of measured data revealed that the internal connection type showed significantly higher First-RTV compared to the external connection type, however, no significant differences in Second-RTV were found. Both experimental groups 1and 2 showed a decrease in RTVs for both implant types, while the control group showed a decrease in RTV only for the internal type. The internal connection type required a significantly larger rotation angle during the tightening and loosening process. Conclusion . Within the limitations of this study, both artificial saliva contamination and CHX cleansing, as well as sandblasting, decreased RTV in both internal and external connection types. Internal connections were more susceptible to the effects of contaminants.

The anticancer drugs have evolved significantly, spanning molecular targeted therapeutics (MTTs), immune checkpoint inhibitors (ICIs), chimeric antigen receptor T-cell (CAR-T) therapy, and antibody-drug conjugates (ADCs). Complications associated with these drugs vary widely based on their mechanisms of action. MTTs that target angiogenesis can often lead to complications related to ischemia or endothelial damage across various organs, whereas non-anti-angiogenic MTTs present unique complications derived from their specific pharmacological actions. ICIs are predominantly associated with immunerelated adverse events, such as pneumonitis, colitis, hepatitis, thyroid disorders, hypophysitis, and sarcoid-like reactions. CAR-T therapy causes unique and severe complications including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. ADCs tend to cause complications associated with cytotoxic payloads. A comprehensive understanding of these drug-specific toxicities, particularly using medical imaging, is essential for providing optimal patient care. Based on this knowledge, radiologists can play a pivotal role in multidisciplinary teams. Therefore, radiologists must stay up-to-date on the imaging characteristics of these complications and the mechanisms underlying novel anticancer drugs.

For patients with edentulous maxillae, creating a prosthetic treatment plan involves considering anatomical factors, aesthetics, the patient’s financial situation, and oral hygiene capabilities. In this case, CAD-CAM technology was used to accurately plan implant placements for a full arch fixed restoration based on the design of the final prosthesis. A customized surgical guide ensured precise implant placement and a provisional restoration was created using CAD-CAM. The definitive prosthesis was then created based on the second provisional restoration that has been previously used and adjusted by the patient. This approach achieved an excellent functional and aesthetic outcome, highlighting the benefits of digital approach and its potential for further clinical applications.

Purpose: . The purpose of this study is to analyze the biomechanical differences in rotation angle-torque according to the type of implant and to compare the effects of contamination and sandblasting on the removal torque value (RTV) of abutment screws. Materials and methods: . For this study, an automated device for tightening and loosening implant screws was developed, and each 15 implant-abutment complexes of external and internal connection type were prepared, divided into three groups according to the surface treatment of the screw:control group (no treatment), experimental group-1 (artificial saliva contamination and chlorhexidine (CHX) rinsing), and experimental group-2 (artificial saliva contamination, CHX rinsing, and subsequent 50 µm Al 2 O 3 sandblasting). FirstRTV was measured for each group, followed by different post-treatment procedures for the screws, and then Second-RTV was measured. During the procedure, the removal torque value and rotation angle vs. time were recorded at a 20 data/s.A standardized protocol was followed for all the tightening and loosening procedures: screw was tightened with 30 Ncm torque and maintained for 5 s, and then rotated in the reverse direction until the torque value reached 0 Ncm. After 10min of rest period, the screws were loosened to initial point. Results: . Statistical analysis of measured data revealed that the internal connection type showed significantly higher First-RTV compared to the external connection type, however, no significant differences in Second-RTV were found. Both experimental groups 1and 2 showed a decrease in RTVs for both implant types, while the control group showed a decrease in RTV only for the internal type. The internal connection type required a significantly larger rotation angle during the tightening and loosening process. Conclusion . Within the limitations of this study, both artificial saliva contamination and CHX cleansing, as well as sandblasting, decreased RTV in both internal and external connection types. Internal connections were more susceptible to the effects of contaminants.

Purpose: This study evaluated the postoperative quality of life (QoL) after various types of gastrectomy for gastric cancer. Materials and Methods: A multicenter prospective observational study was conducted in Korea using the Korean Quality of Life in Stomach Cancer Patients Study (KOQUSS)-40, a new QoL assessment tool focusing on postgastrectomy syndrome. Overall, 496 patients with gastric cancer were enrolled, and QoL was assessed at 5 time points: preoperatively and at 1, 3, 6, and 12 months after surgery. Results: Distal gastrectomy (DG) and pylorus-preserving gastrectomy (PPG) showed significantly better outcomes than total gastrectomy (TG) and proximal gastrectomy (PG) with regard to total score, indigestion, and dysphagia. DG, PPG, and TG also showed significantly better outcomes than PG in terms of dumping syndrome and worry about cancer. Postoperative QoL did not differ significantly according to anastomosis type in DG, except for Billroth I anastomosis, which achieved better bowel habit change scores than the others. No domains differed significantly when comparing double tract reconstruction and esophagogastrostomy after PG. The total QoL score correlated significantly with postoperative body weight loss (more than 10%) and extent of resection (P<0.05 for both).Reflux as assessed by KOQUSS-40 did not correlate significantly with reflux observed on gastroscopy 1 year postoperatively (P=0.064). Conclusions Our prospective observation using KOQUSS-40 revealed that DG and PPG lead to better QoL than TG and PG. Further study is needed to compare postoperative QoL according to anastomosis type in DG and PG.

Purpose: Since 1995, the Korean Gastric Cancer Association (KGCA) has been periodically conducting nationwide surveys on patients with surgically treated gastric cancer. This study details the results of the survey conducted in 2023. Materials and Methods: The survey was conducted from March to December 2024 using a standardized case report form. Data were collected on 86 items, including patient demographics, tumor characteristics, surgical procedures, and surgical outcomes. The results of the 2023 survey were compared with those of previous surveys. Results: Data from 12,751 cases were collected from 66 institutions. The mean patient age was 64.6 years, and the proportion of patients aged ≥71 years increased from 9.1% in 1995 to 31.7% in 2023. The proportion of upper-third tumors slightly decreased to 16.8% compared to 20.9% in 2019. Early gastric cancer accounted for 63.1% of cases in 2023.Regarding operative procedures, a totally laparoscopic approach was most frequently applied (63.2%) in 2023, while robotic gastrectomy steadily increased to 9.5% from 2.1% in 2014.The most common anastomotic method was the Billroth II procedure (48.8%) after distal gastrectomy and double-tract reconstruction (51.9%) after proximal gastrectomy in 2023.However, the proportion of esophago-gastrostomy with anti-reflux procedures increased to 30.9%. The rates of post-operative mortality and overall complications were 1.0% and 15.3%, respectively. Conclusions The results of the 2023 nationwide survey demonstrate the current status of gastric cancer treatment in Korea. This information will provide a basis for future gastric cancer research.

We describe the updated Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of cervical cancer, version 5.1. The KSGO announced the fifth version of its clinical practice guidelines for the management of cervical cancer in March 2024. The selection of the key questions and the systematic reviews were based on data available up to December 2022. Between 2023 and 2024, substantial findings from large-scale clinical trials and new advancements in cervical cancer research remarkably emerged. Therefore, based on the existing version 5.0, we updated the guidelines with newly accumulated clinical data and added 4 new key questions reflecting the latest insights in the field of cervical cancer. For each question, recommendation was formulated with corresponding level of evidence and grade of recommendation, all established through expert consensus.